We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ImmunoMet Therapeutics Raises $5.0 million in a Series B Financing

News   Mar 10, 2017 | Original Story from ImmunoMet

 
ImmunoMet Therapeutics Raises $5.0 million in a Series B Financing
 
 
 

RELATED ARTICLES

Probing Yeast Cells to Understand Cell Misregulation

News

Manipulating yeast with optogenetics and microfluidics to explore the MAP kinase pathway may be key for drug discovery.

READ MORE

Computational Models of the Human Lung: Potential for Personalized Medicine & Inhalation Toxicology

News

Combining high-performance computing, high-fidelity modeling, and high-resolution medical imaging, produces simulations that have the potential to contribute to new diagnostic tools and treatment options for respiratory disease.

READ MORE

Therapeutic RNAs get Helping Hand from Green Tea Compound

News

An antioxidant in green tea called epigallocatechin gallate has been found to have a surprising use: sneaking therapeutic RNAs into cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE